Registered Rwanda · Rwanda FDA

TRAUSAN

CITICHOLONE

Rwanda FDA-HMP-MA-1648 ORAL SOLUTION 100MG/ML

What it does

Citicholone is a medication used to support brain health and cognitive function.

Commonly used for: memory problems, cognitive decline, Alzheimer's disease

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
Rwanda FDA-HMP-MA-1648
Registration date
17/08/2024
Expiry date
16/08/2029
Status
Registered
Active ingredient
CITICHOLONE
Dosage form
ORAL SOLUTION
Strength
100MG/ML
Pack size
50ML Bottles
Therapeutic class
-
Manufacturer / MAH
Faes Farma
Country of origin
SPAIN
Manufacturer location
Planta 5°, Edificio 2, Parque Empresarial Cristalia, C. Vía de los Poblados, 3, Hortaleza, 28033 Madrid, Spain

Source: Rwanda Food and Drugs Authority · fetched 2026-03-11 22:07:04 · updated 2026-09-21 02:30:19

Disclaimer: This information is sourced from Rwanda Food and Drugs Authority (Rwanda). Always consult a qualified healthcare professional before using any medication.

About this medicine

Citicholone is a medication used to support brain health and cognitive function.

What it treats

  • memory problems
  • cognitive decline
  • Alzheimer's disease

How it works

It helps improve communication between brain cells, which can enhance memory and thinking skills.

Who it's for

Citicholone is suitable for adults experiencing cognitive difficulties or age-related memory issues.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: citicholone

Citicholone is a drug that primarily acts as a cognitive enhancer, belonging to the class of nootropic agents. It is known for its potential in improving memory, learning capabilities, and overall cognitive function. Citicholone is often explored for use in conditions related to cognitive impairment and neurodegenerative diseases.

Indications

  • Cognitive impairment
  • Age-related cognitive decline
  • Neurodegenerative disorders such as Alzheimer's disease
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Traumatic brain injury

Dosage

Children: Refer to established guidelines or consult a healthcare provider for appropriate dosing information.

Adults: Refer to established guidelines or consult a healthcare provider for appropriate dosing information.

Mechanism of action

The precise mechanism of action of citicholone is not fully elucidated. However, it is believed to enhance cholinergic neurotransmission, thereby increasing the levels of acetylcholine in the brain. This action may contribute to its cognitive-enhancing effects, as acetylcholine is critical for learning and memory processes. Citicholone may also exhibit neuroprotective properties and influence neuroplasticity through various signaling pathways.

Pharmacodynamics

Citicholone exerts its effects primarily through modulation of neurotransmitter systems, particularly the cholinergic system, which is essential for cognitive processes. It may also interact with other neurotransmitter systems, enhancing synaptic plasticity and promoting neuronal health. The overall pharmacodynamic profile suggests a potential benefit in improving cognitive functions and protecting neuronal integrity.

Pharmacokinetics

The pharmacokinetics of citicholone, including its absorption, distribution, metabolism, and excretion, are not well-documented in available literature. However, like other nootropics, it may be absorbed via the gastrointestinal tract, with a variable bioavailability. The drug is likely to be metabolized in the liver, with elimination through renal pathways. Further studies are needed to define its pharmacokinetic parameters accurately.

Pregnancy

Limited information is available regarding the safety of citicholone during pregnancy. It is advisable to consult healthcare professionals before use.

Breast-feeding

The excretion of citicholone in human milk is not well studied. Caution is recommended when administering to breastfeeding women.

Storage

Store at room temperature, protected from light and moisture.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.